The FDA approved nerandomilast (Jascayd) tablets for idiopathic pulmonary fibrosis (IPF), the first new product for the progressive lung condition in over a decade, the agency announced on Tuesday.

The map showed levels of fine particle (PM2.5) pollution in the "unhealthy" category spanning communities east and south of ...

Keith Rochfort receives funding from Research Ireland. As colder months set in, respiratory infections begin to climb: everything from the common cold and flu to COVID. It’s a time when healthy lungs ...

More than 10 years after bringing one of the first idiopathic pulmonary fibrosis (IPF) drugs to market, Boehringer Ingelheim is freshening up its leadership in the rare lung disease space with a newly ...

At 47 years of age, Emi Bossio was feeling good about where she was. She had a successful law practice, two growing children and good health. Then she developed a nagging cough. The diagnosis to come ...

Wyatt Linderman is an organ donor recipient success story and pays tribute every year to his donor. Wyatt Linderman is an organ donor recipient success story and pays tribute every year to his donor.

LinkedIn has filed a lawsuit against Delaware company ProAPIs Inc. and its founder and CTO, Rehmat Alam, for allegedly scraping legitimate data through more than a million fake accounts. ProAPIs ...

AMSTERDAM — With new research shedding light on how our food affects respiratory function and the progression of disease, interest in the role of diet in lung health is increasing. The reasoning ...

Devon Witherspoon and Julian Love entered the game against the Tampa Bay Buccaneers as inactive. Riq Woolen suffered a concussion. Nehemiah Pritchett is also being evaluated for a concussion. Nick ...

A magnetic microrobot navigates lung airways, drills microlesions, gathers biomarkers, and rapidly classifies cancer tissue with Raman sensing and machine learning in a single integrated workflow.

Please provide your email address to receive an email when new articles are posted on . The FDA approved the combination of lurbinectedin and atezolizumab as first-line maintenance treatment for ...

Implementation of Real-World Diagnostic Strategies in Taiwan for the Identification of Targetable Oncogenic Driver Alterations in Non–Small Cell Lung Cancer We conducted a multicenter retrospective ...